Citation Impact
Citing Papers
SNAI1 Is Required for Tumor Growth and Lymph Node Metastasis of Human Breast Carcinoma MDA-MB-231 Cells
2007
HIF-1-Mediated Suppression of Acyl-CoA Dehydrogenases and Fatty Acid Oxidation Is Critical for Cancer Progression
2014 StandoutNobel
Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors
2015
Breast cancer
2019 Standout
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort
2015
Endogenous human microRNAs that suppress breast cancer metastasis
2008 StandoutNature
Synapses and Alzheimer's Disease
2012 StandoutNobel
Proteasome inhibitors in cancer therapy
2017
Pancreatic cancer
2004 Standout
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
2008 StandoutNature
Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
2012 Standout
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
p53 Regulates the Expression of the Tumor Suppressor Gene Maspin
2000
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Otto Warburg's contributions to current concepts of cancer metabolism
2011 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial
2003
Tumor Cell Metabolism: Cancer's Achilles' Heel
2008 Standout
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Complex networks orchestrate epithelial–mesenchymal transitions
2006 Standout
Pyruvate kinase type M2 and its role in tumor growth and spreading
2005
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Glycogen synthase kinase 3: a drug target for CNS therapies
2004
Metastasis suppressors alter the signal transduction of cancer cells
2003
Extracellular matrix structure
2015 Standout
Regulation of cancer cell metabolism
2011 Standout
Non-irradiation-derived reactive oxygen species (ROS) and cancer: therapeutic implications
2006
Remodelling the extracellular matrix in development and disease
2014 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Diabetic foot ulcers
2003 Standout
Live or let die: the cell's response to p53
2002 Standout
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
2008 Standout
Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer
2005
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
2009
Leaving the neighborhood: molecular mechanisms involved during epithelial‐mesenchymal transition
2001
Pancreatic Cancer
2010 Standout
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Claudin-1 contributes to the epithelial barrier function in MDCK cells
1999
The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation
2012
Shear Stress Regulates Occludin and VEGF Expression in Porcine Arterial Endothelial Cells
2002
Fatty acid—Mediated activation of vascular endothelial cells
2000
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
2010 StandoutNature
Microbiota-Generated Metabolites Promote Metabolic Benefits via Gut-Brain Neural Circuits
2014 Standout
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers
1999
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study
2008 Standout
Beyond EGFR and ALK inhibition: Unravelling and exploiting novel genetic alterations in advanced non small-cell lung cancer
2015
Regulation of angiogenesis and endothelial cell motility by matrix-bound fibroblasts
1999
Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy
2007
Pancreatic cancer
2011 Standout
Albumin-bound paclitaxel: a next-generation taxane
2006
Protection from Pulmonary Fibrosis in Leukotriene-Deficient Mice
2002
Occludin Protein Family: Oxidative Stress and Reducing Conditions
2011
SuFEx Click Chemistry Enabled Late-Stage Drug Functionalization
2018 StandoutNobel
Peritumoral Fibroblast SPARC Expression and Patient Outcome With Resectable Pancreatic Adenocarcinoma
2007
Medroxyprogesterone Acetate Elevation of Nm23-H1 Metastasis Suppressor Expression in Hormone Receptor–Negative Breast Cancer
2005
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Fulvestrant (Faslodex®)—How to Make a Good Drug Better
2007
Nanoparticle albumin-bound (nab™)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer
2010
The extracellular matrix at a glance
2010 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Transcriptional control of human p53-regulated genes
2008 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.
2002
Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
2003
Maspin Functions as Tumor Suppressor by Increasing Cell Adhesion to Extracellular Matrix in Prostate Tumor Cells
2003
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
2011
Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells
2003
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of Richard Bryce being referenced
Regulation of Tight Junction Permeability and Occludin Expression by Polyunsaturated Fatty Acids
1998
Effect of dietary GLA+/?tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenografts
2001
Increased levels of SPARC (osteonectin) in human breast cancer tissues and its association with clinical outcomes
2005
Peroxisome proliferator activated receptor-γ (PPAR-γ) mediates the action of gamma linolenic acid in breast cancer cells
2000
γ-Linolenic acid regulates the expression and secretion of SPARC in human cancer cells
2005
Gamma linolenic acid with tamoxifen as primary therapy in breast cancer
2000
Gamma Linolenic Acid Regulates Expression of Maspin and the Motility of Cancer Cells
1997
The effects of n-6 polyunsaturated fatty acids on the expression of nm-23 in human cancer cells
1998
Gamma linolenic acid regulates gap junction communication in endothelial cells and their interaction with tumour cells
1997
Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosourea
1999
Essential fatty acids: molecular and cellular basis of their anti-cancer action and clinical implications
1998
Regulation of desmosomal cell adhesion in human tumour cells by polyunsaturated fatty acids
1997
Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)
2012
Randomized, dose-finding phase III study of lithium gamolenate in patients with advanced pancreatic adenocarcinoma
2001
Neratinib + capecitabine versus lapatinib + capecitabine in patients with HER2+ metastatic breast cancer previously treated with ≥ 2 HER2-directed regimens: Findings from the multinational, randomized, phase III NALA trial.
2019
Neratinib (N) with or Without Temsirolimus (Tem) in Patients (Pts) with Non-Small Cell Lung Cancer (Nsclc) Carrying Her2 Somatic Mutations: an International Randomized Phase Ii Study
2014